Kwality Pharmaceuticals balance sheet

As of Mar 2024

Total assets: ₹398cr+11.5% on Mar 2023
Shareholders' equity: ₹226cr+11.8% on Mar 2023

₹ crore except per share

Tap a line for its trend	FY24Mar 2024	FY23Mar 2023	FY22Mar 2022

Non-current assets
	138	120	90.8
	0.0	14.3	12.1
	—	—	4.3
	3.5	3.5	—
	—	—	8.1
	3.5	—	—
	0.1	134	0.0
	12.4	11.6	0.0
	154	149	—
Current assets
	78.4	86.3	53.4
	116	73.3	70.7
	—	—	10.9
	1.4	1.8	—
	—	10.3	92.4
	27.6	24.6	0.0
	243	208	—
	398	357	343
Equity
	10.4	10.4	10.4
	216	192	—
	226	202	—
	226	202	—
Liabilities
	19.6	—	—
	19.6	—	—
	0.2	—	—
	0.0	0.4	0.3
	19.8	28.6	—
	78.6	—	—
	44.3	35.2	34.5
	0.2	—	—
	19.1	—	31.1
	152	126	—
	172	155	—
	398	357	343

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

KPL₹3,696.70

Kwality Pharmaceuticals Limited

· Pharma & Health

₹ CrorePeersBPLPHARMA JENBURPH MAKERSL NOVARTIND PARNAXLAB SGRL SHUKRAPHAR SUNLOC

View

In ₹ Crore except Per Share As of	FY22 31/03/2022	FY23 31/03/2023	FY24 31/03/2024
Non-current Assets
+ Property, Plant & Equipment	90.8	119.6	138.2
+ Capital Work-in-Progress	12.1	14.3	0.0
+ Intangibles under Development	4.3	—	—
+ Non-current Investments	—	3.5	3.5
+ Long-term Loans	8.1	—	—
Non-current Financial Assets	—	—	3.5
+ Deferred Tax Assets	0.0	133.9	0.1
+ Other Non-current Assets	0.0	11.6	12.4
Total Non-current Assets	—	149.1	154.2
Current Assets
+ Inventories	53.4	86.3	78.4
+ Trade Receivables	70.7	73.3	116.0
+ Cash & Cash Equivalents	10.9	—	—
+ Other Bank Balances	—	1.8	1.4
+ Short-term Loans	92.4	10.3	—
+ Other Current Assets	0.0	24.6	27.6
Total Current Assets	—	207.5	243.4
Total Assets	342.7	356.6	397.6
Equity
+ Equity Share Capital	10.4	10.4	10.4
+ Other Equity / Reserves	—	191.6	215.6
Equity — Owners of Parent	—	202.0	225.9
Total Equity	—	202.0	225.9
Liabilities
+ Borrowings — Non-current	—	—	19.6
Non-current Financial Liabilities	—	—	19.6
+ Provisions — Non-current	—	—	0.2
+ Deferred Tax Liabilities	0.3	0.4	0.0
Non-current Liabilities	—	28.6	19.8
+ Borrowings — Current	—	—	78.6
+ Trade Payables	34.5	35.2	44.3
+ Provisions — Current	—	—	0.2
+ Other Current Liabilities	31.1	—	19.1
Current Liabilities	—	125.9	151.9
Total Liabilities	—	154.6	171.6
Total Equity & Liabilities	342.7	356.6	397.6

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY24 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.